Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,539 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The remote diet intervention to reduce Long COVID symptoms trial (ReDIRECT): protocol for a randomised controlled trial to determine the effectiveness and cost-effectiveness of a remotely delivered supported weight management programme for people with Long COVID and excess weight, with personalised improvement goals.
Haag L, Richardson J, Cunningham Y, Fraser H, Brosnahan N, Ibbotson T, Ormerod J, White C, McIntosh E, O'Donnell K, Sattar N, McConnachie A, Lean MEJ, Blane DN, Combet E. Haag L, et al. Among authors: sattar n. NIHR Open Res. 2023 Aug 3;2:57. doi: 10.3310/nihropenres.13315.2. eCollection 2022. NIHR Open Res. 2023. PMID: 37881302 Free PMC article.
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.
Garvey WT, Frias JP, Jastreboff AM, le Roux CW, Sattar N, Aizenberg D, Mao H, Zhang S, Ahmad NN, Bunck MC, Benabbad I, Zhang XM; SURMOUNT-2 investigators. Garvey WT, et al. Among authors: sattar n. Lancet. 2023 Aug 19;402(10402):613-626. doi: 10.1016/S0140-6736(23)01200-X. Epub 2023 Jun 26. Lancet. 2023. PMID: 37385275 Clinical Trial.
Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial.
Verma S, Dhingra NK, Butler J, Anker SD, Ferreira JP, Filippatos G, Januzzi JL, Lam CSP, Sattar N, Peil B, Nordaby M, Brueckmann M, Pocock SJ, Zannad F, Packer M; EMPEROR-Reduced trial committees and investigators. Verma S, et al. Among authors: sattar n. Lancet Diabetes Endocrinol. 2022 Jan;10(1):35-45. doi: 10.1016/S2213-8587(21)00292-8. Epub 2021 Nov 30. Lancet Diabetes Endocrinol. 2022. PMID: 34861154
Non-coronary peripheral arterial complications in people with type 2 diabetes: a Swedish retrospective cohort study.
Rawshani A, Eliasson B, Boren J, Sattar N, Bhatt D, El-Khalili L, Nordanstig J, Avdic T, Beckman JA, Gerstein HC, McGuire DK, Omerovic E, Rawshani A. Rawshani A, et al. Among authors: sattar n. Lancet Reg Health Eur. 2024 Mar 19;39:100888. doi: 10.1016/j.lanepe.2024.100888. eCollection 2024 Apr. Lancet Reg Health Eur. 2024. PMID: 38803635 Free PMC article.
Non-coronary arterial outcomes in people with type 1 diabetes mellitus: a Swedish retrospective cohort study.
Avdic T, Eliasson B, Rawshani A, Boren J, Gerstein HC, Nordanstig J, Rihawi M, Beckman JA, McGuire DK, Omerovic E, Sattar N, Bhatt DL, Rawshani A. Avdic T, et al. Among authors: sattar n. Lancet Reg Health Eur. 2024 Feb 15;39:100852. doi: 10.1016/j.lanepe.2024.100852. eCollection 2024 Apr. Lancet Reg Health Eur. 2024. PMID: 38803631 Free PMC article.
Long COVID and cardiovascular disease: a prospective cohort study.
Lawson CA, Moss AJ, Arnold JR, Bagot C, Banerjee A, Berry C, Greenwood J, Hughes AD, Khunti K, Mills NL, Neubauer S, Raman B, Sattar N, Leavy OC, Richardson M, Elneima O, McAuley HJ, Shikotra A, Singapuri A, Sereno M, Saunders R, Harris V, Houchen-Wolloff L, Greening NJ, Harrison E, Docherty AB, Lone NI, Quint JK, Chalmers J, Ho LP, Horsley A, Marks M, Poinasamy K, Evans R, Wain LV, Brightling C, McCann GP; PHOSP-COVID Study Collaborative Group. Lawson CA, et al. Among authors: sattar n. Open Heart. 2024 May 27;11(1):e002662. doi: 10.1136/openhrt-2024-002662. Open Heart. 2024. PMID: 38802280 Free PMC article.
Response to "Importance of method assumptions".
Wade KH, Timpson NJ, Hamilton FW, Sattar N, Carslake D, Davey Smith G. Wade KH, et al. Among authors: sattar n. Obesity (Silver Spring). 2024 May 21. doi: 10.1002/oby.24056. Online ahead of print. Obesity (Silver Spring). 2024. PMID: 38773930 No abstract available.
Obesity and Cardiovascular Disease: A New Dawn.
Sattar N, Neeland IJ, McGuire DK. Sattar N, et al. Circulation. 2024 May 21;149(21):1621-1623. doi: 10.1161/CIRCULATIONAHA.123.065485. Epub 2024 May 20. Circulation. 2024. PMID: 38768272 Free article. Review. No abstract available.
1,539 results